Howard C. Dittrich

Founder at Advanced Endovascular Therapeutics, Inc.

71 year

Health Technology

Consumer Services

Retail Trade

Active connections

Name	Gender	Age	Linked companies	Collaboration
Randall E. Woods	M	72	NovaCardia, Inc. NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. Sequel Pharmaceuticals, Inc. Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sequel Pharmaceuticals, Inc. engaged in the development of cardiovascular drug. The company was founded in 2007 and was headquartered in San Diego, CA. Sorbent Therapeutics, Inc. Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA.	20 years
Robert F. Baltera	M	58	Laguna Pharmaceuticals, Inc. Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	8 years
Brian K. Farmer	M	-	Sequel Pharmaceuticals, Inc. Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sequel Pharmaceuticals, Inc. engaged in the development of cardiovascular drug. The company was founded in 2007 and was headquartered in San Diego, CA. NovaCardia, Inc. NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. Laguna Pharmaceuticals, Inc. Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	9 years
Dennis Fenton	M	72	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	6 years
Julie Iwashita	F	-	Laguna Pharmaceuticals, Inc. Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. Sorbent Therapeutics, Inc. Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	5 years
Jerry Colca	M	-	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	9 years
Daniel J. Estes	M	43	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	7 years
David van Andel	M	64	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	8 years
Nilesh Kumar	M	47	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	7 years
Robert Zerbe	M	73	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	8 years
John Snyder	M	-	Laguna Pharmaceuticals, Inc. Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	-
Mike J. Jandernoa	M	73	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	8 years
Brian Finck	M	-	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	9 years
Marsha Chandler	M	79	University of California San Diego	27 years
Sanjiv M. Narayan	M	-	University of California San Diego	16 years
William Sandborn	M	61	University of California San Diego	13 years
Andrew Knudten	M	-	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	5 years
Angeline K. Shashlo	F	-	Cirius Therapeutics, Inc. Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA.	-
Tony Chou	M	63	University of California San Diego	30 years
C. Lowell Parsons	M	78	University of California San Diego	36 years
Lin-Tsing Yu	M	80	University of California San Diego	30 years
David G. Lowe	M	67	NovaCardia, Inc. NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.	18 years
Michael Karin	M	-	University of California San Diego	38 years
Dennis A. Carson	M	77	University of California San Diego	34 years
Ronald L. Graham	M	88	University of California San Diego	25 years
Robert W. Conn	M	81	University of California San Diego	20 years
Lawrence B. Krause	M	93	University of California San Diego	38 years
Gordon Hanson	M	60	University of California San Diego	23 years
Richard Feinberg	M	76	University of California San Diego	28 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Patrick Keran	M	52	Mast Therapeutics, Inc. Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.	9 years
Steven Mickelsen	M	-	Farapulse, Inc. Farapulse, Inc. Medical SpecialtiesHealth Technology Farapulse, Inc. engages in the development of medical devices. Its products are: Endo Farawave, a percutaneous catheter designed to create transmural and contiguous lesions on the endocardium of the left atrium to isolate the pulmonary veins and EPI Faraone, s designed to create a box lesion around all pulmonary veins from an epicardial placement of the catheter for the treatment of atrial fibrillation. The company was founded by Steven Mickelsen in 2014 and is headquartered in Iowa City, IA.	4 years
Brandi Roberts	F	50	Mast Therapeutics, Inc. Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.	6 years
Eckard Weber	M	73	NovaCardia, Inc. NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.	6 years
Salman Khetani	M	-	University of California San Diego	6 years
Bobba Venkatadri	M	79	Molecular Biosystems, Inc. Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA.	5 years
Brenda Turner	F	-	University of California San Diego	6 years
Thomas O'Neil	M	59	Sorbent Therapeutics, Inc. Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA.	-
Glenn Joseph Busch	M	-	University of California San Diego	8 years
Yu Shi Shen	M	46	University of California San Diego	3 years
Ellen Chen	F	-	University of California San Diego	4 years
Elizabeth Hougen	F	62	Molecular Biosystems, Inc. Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA.	8 years
William O'Connor	M	-	University of California San Diego	5 years
Jeffrey Stein	M	69	University of California San Diego	5 years
Eric Apaydin	M	-	University of California San Diego	5 years
Dan Mytels	M	-	University of California San Diego	5 years
Richard Castle	M	-	University of California San Diego	4 years
Arthur M. Brown	M	-	Laguna Pharmaceuticals, Inc. Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.	-
Sau Kuen Yu	F	48	University of California San Diego	5 years
Tony Craddock	M	-	University of California San Diego	8 years
Mark Mugerditchian	M	-	NovaCardia, Inc. NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. Laguna Pharmaceuticals, Inc. Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.	-
Lloyd Rowland	M	67	Alliance Pharmaceutical Corp. Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA.	8 years
David Ramsay	M	59	Mast Therapeutics, Inc. Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.	6 years
Franklin J. Miller	M	83	University of California San Diego	9 years
Bob Whiton	M	-	University of California San Diego	5 years
Lewis J. Shuster	M	68	Mast Therapeutics, Inc. Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.	5 years
Jack Lief	M	78	Mast Therapeutics, Inc. Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.	9 years
Peter Greenleaf	M	54	Mast Therapeutics, Inc. Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.	-
Stefan Loren	M	60	University of California San Diego	11 years
Emily Warren	F	-	University of California San Diego	4 years
Ed Ruth	M	-	University of California San Diego	4 years
Kevin Sutantyo	M	-	University of California San Diego	4 years
Ksenia Koban	F	-	University of California San Diego	4 years
Kang Man Wong	M	40	University of California San Diego	4 years
Arcediano jason	M	-	University of California San Diego	5 years
Scott Moonly	M	-	University of California San Diego	5 years
Silvia Mah	M	-	University of California San Diego	7 years
Akash Bakshi	M	35	University of California San Diego	4 years
Tyler Korman	M	45	University of California San Diego	4 years
Marcos Rivera	M	-	University of California San Diego	4 years
Rachel Wu	F	41	University of California San Diego	4 years
Sagnik Nandy	M	-	University of California San Diego	4 years
Xiaohan Zhu	M	-	University of California San Diego	2 years
Peter Heller Finkel	M	-	University of California San Diego	4 years
Wilson Greg	M	-	University of California San Diego	5 years
Paul-Peter Tak	M	64	University of California San Diego	5 years
Tim Liu	M	-	University of California San Diego	4 years
Conrad Hummel	M	-	University of California San Diego	3 years
Xuhui Shao	M	-	University of California San Diego	2 years
Blake Schneider	M	-	University of California San Diego	4 years
Lawrence Alan Taylor	M	-	University of California San Diego	5 years
Marsha Otto Riley	F	-	University of California San Diego	2 years
Jason Daniel Kantor	M	-	University of California San Diego	4 years
Kevin D. Blair	M	-	University of California San Diego	4 years
Gary Seelhorst	M	52	University of California San Diego	4 years
Mitch J. Zeitz	M	-	University of California San Diego	4 years
Andreas Brandstetter	M	55	University of California San Diego	3 years
Walter Luyten	M	-	University of California San Diego	3 years
Reyhaneh Zand	F	-	University of California San Diego	4 years
Randolph Simpson	M	55	University of California San Diego	4 years
Sangeeta Bhatia	M	55	University of California San Diego	7 years
Jeff Daems	M	-	University of California San Diego	4 years
Kirstin Kriz	M	49	University of California San Diego	4 years
Dev K. Mishra	M	-	University of California San Diego	3 years
Reid Tomlin	M	-	University of California San Diego	4 years
Daniel Riskin	M	-	University of California San Diego	5 years
Beatriz Acevedo-Greiff	F	-	University of California San Diego	4 years
Ross Trejo Locher	M	-	University of California San Diego	4 years
Anthony Di Leva	M	-	University of California San Diego	4 years

Statistics

Country	Connections	% of total
United States	98	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections